|
|
Volumn 10, Issue 11, 2009, Pages 1028-1029
|
|
Errata (DOI:10.1016/S1470-2045(09)70323-7);Adjuvant! When the new world meets the old world
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ESTROGEN RECEPTOR;
PROGESTERONE RECEPTOR;
ADJUVANT THERAPY;
BREAST CANCER;
CANCER GRADING;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER REGISTRY;
CANCER RELAPSE;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMORBIDITY;
EUROPE;
HUMAN;
INDIVIDUALIZATION;
LETTER;
LIFE EXPECTANCY;
LYMPH NODE METASTASIS;
MEDICAL DECISION MAKING;
OVERALL SURVIVAL;
PATIENT CARE;
PATIENT DECISION MAKING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROBABILITY;
RECURRENCE RISK;
RISK BENEFIT ANALYSIS;
TUMOR VOLUME;
UNITED KINGDOM;
UNITED STATES;
VALIDATION STUDY;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CALIBRATION;
CHEMOTHERAPY, ADJUVANT;
DECISION SUPPORT TECHNIQUES;
DISCRIMINANT ANALYSIS;
DISEASE-FREE SURVIVAL;
EUROPE;
FEMALE;
HUMANS;
INTERNET;
MODELS, BIOLOGICAL;
ONLINE SYSTEMS;
PATIENT SELECTION;
PRACTICE GUIDELINES AS TOPIC;
PREDICTIVE VALUE OF TESTS;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 71249157771
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(09)70357-2 Document Type: Erratum |
|
Times cited : (4)
|
|
References (6)
|
